October 5, 2020

Diaceutics Research Predicts NSCLC US Testing Market to Reach $3.6bn by 2025, but Solution Still Needed to Improve Patient Outcomes

PARSIPPANY, N.J.–(BUSINESS WIRE)–Diaceutics publishes new research which predicts that the US Non-Small Cell Lung Cancer (NSCLC) testing market will reach $3.6 billion by 2025.


Leave Comment


Your Name *
Your Email *
Your Website
Comment *